|
NECAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.613200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.357800E-01 |
| Normal-vs-Stage2 |
9.559600E-01 |
| Normal-vs-Stage3 |
3.440500E-02 |
| Normal-vs-Stage4 |
3.348400E-02 |
| Stage1-vs-Stage2 |
6.246400E-01 |
| Stage1-vs-Stage3 |
4.477000E-03 |
| Stage1-vs-Stage4 |
3.455900E-03 |
| Stage2-vs-Stage3 |
1.443430E-01 |
| Stage2-vs-Stage4 |
1.221830E-01 |
| Stage3-vs-Stage4 |
8.682400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.127800E-01 |
| Normal-vs-AfricanAmerican |
2.239600E-03 |
| Normal-vs-Asian |
6.552800E-01 |
| Caucasian-vs-AfricanAmerican |
7.237000E-03 |
| Caucasian-vs-Asian |
8.641800E-01 |
| AfricanAmerican-vs-Asian |
3.058000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.397570E-01 |
| Normal-vs-Female |
8.177200E-01 |
| Male-vs-Female |
7.243900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.02699999999734E-05 |
| Normal-vs-Age(41-60Yrs) |
4.244600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.413600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.990600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.172200E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.208700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.576500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.997400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.092800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.628400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.345800E-01 |
| Normal-vs-Grade 2 |
2.213800E-01 |
| Normal-vs-Grade 3 |
8.555700E-02 |
| Normal-vs-Grade 4 |
7.556600E-04 |
| Grade 1-vs-Grade 2 |
7.989800E-01 |
| Grade 1-vs-Grade 3 |
1.664150E-01 |
| Grade 1-vs-Grade 4 |
2.845600E-02 |
| Grade 2-vs-Grade 3 |
1.378030E-03 |
| Grade 2-vs-Grade 4 |
2.14689999999962E-06 |
| Grade 3-vs-Grade 4 |
1.535680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.570800E-04 |
| Normal-vs-ccB subtype |
1.882700E-03 |
| ccA subtype-vs-ccB subtype |
3.7212455339386E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.687400E-01 |
| Normal-vs-N1 |
1.336270E-02 |
| N0-vs-N1 |
8.461700E-02 |
|
|
